- Report
- August 2025
- 336 Pages
Global
From €5205EUR$6,129USD£4,350GBP
- Report
- January 2025
- 714 Pages
Global
From €4351EUR$4,950USD£3,763GBP
- Report
- January 2025
- 126 Pages
Global
From €2636EUR$2,999USD£2,280GBP
- Report
- February 2025
- 130 Pages
Global
From €2189EUR$2,490USD£1,893GBP
- Report
- March 2025
- 175 Pages
Global
From €3947EUR$4,490USD£3,414GBP
- Report
- August 2025
- 188 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- August 2025
- 195 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- June 2025
- 180 Pages
Global
From €3955EUR$4,500USD£3,421GBP
- Report
- July 2025
- 188 Pages
Global
From €3955EUR$4,500USD£3,421GBP
- Report
- April 2025
- 150 Pages
Global
From €3384EUR$3,850USD£2,927GBP
€4263EUR$4,850USD£3,687GBP
- Report
- June 2025
- 400 Pages
Global
From €4350EUR$4,949USD£3,763GBP
From €4307EUR$4,900USD£3,725GBP
- Report
- February 2025
- 169 Pages
Latin America
From €7471EUR$8,500USD£6,462GBP
- Report
- June 2025
- 200 Pages
United States
From €2189EUR$2,490USD£1,893GBP
- Report
- October 2024
- 200 Pages
Europe
From €2189EUR$2,490USD£1,893GBP
- Report
- November 2024
Global
From €4351EUR$4,950USD£3,763GBP
- Report
- November 2024
- 150 Pages
Global
From €5230EUR$5,950USD£4,524GBP
- Report
- August 2025
- 186 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- August 2025
- 182 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- August 2025
- 183 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP

The Next Generation Sequencing (NGS) market is a subset of the biotechnology industry that focuses on the development and application of high-throughput sequencing technologies. NGS technologies enable the rapid and cost-effective sequencing of large amounts of DNA or RNA, allowing for the analysis of genetic variation and gene expression. This technology has been used to identify and characterize genetic mutations, to study gene expression, and to develop new diagnostics and therapeutics. NGS has also been used to study the evolution of viruses and bacteria, and to identify new species.
The NGS market is highly competitive, with a number of companies offering a range of sequencing technologies and services. Some of the major players in the market include Illumina, Thermo Fisher Scientific, BGI, Pacific Biosciences, Oxford Nanopore Technologies, and 10x Genomics. Show Less Read more